Filing Details
- Accession Number:
- 0001209191-22-058874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-28 16:56:54
- Reporting Period:
- 2022-11-23
- Accepted Time:
- 2022-11-28 16:56:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831363 | Terns Pharmaceuticals Inc. | TERN | () | E9 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1764435 | Lav Biosciences Fund V, L.p. | Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3 00000 | No | No | Yes | No | |
| 1844154 | Ltd Venture Spring Oriental | Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3 00000 | No | No | Yes | No | |
| 1844158 | Ltd Holdings Resources Hopewell | Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3 00000 | No | No | Yes | No | |
| 1844279 | Ltd Aqua Lav | Room 606-7, St. George'S Bldg. 2 Ice House Street, Central Hong Kong K3 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-11-23 | 1,000,000 | $5.50 | 405,583 | No | 4 | S | Indirect | See footnotes |
| Common Stock | Disposition | 2022-11-23 | 333,334 | $5.50 | 1,059,523 | No | 4 | S | Indirect | See footnotes |
| Common Stock | Disposition | 2022-11-23 | 166,666 | $5.50 | 529,762 | No | 4 | S | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnotes |
| No | 4 | S | Indirect | See footnotes |
| No | 4 | S | Indirect | See footnotes |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,286,698 | Indirect | See footnotes |
Footnotes
- Shares held by LAV Biosciences Fund V, L.P.
- LAV Corporate GP, Ltd. is the general partner of LAV GP III, L.P., which is the general partner of the parent entity of Hopewell Resources Holdings Limited and Oriental Spring Venture Limited. LAV Corporate IV GP, Ltd., is the general partner of LAV GP IV, L.P., which is the general partner of the parent entity of LAV Aqua Limited. LAV Corporate V GP, Ltd., is the general partner of LAV GP V, L.P., which is the general partner of LAV Biosciences Fund V, L.P. Dr. Yi Shi is the managing partner of LAV Corporate GP, Ltd., LAV Corporate IV GP, Ltd., and LAV Corporate V, L.P. and has all voting and investment power with respect to shares beneficially held by each of Hopewell Resources Holdings Limited, Oriental Spring Venture Limited, LAV Aqua Limited and LAV Biosciences Fund V, L.P. Dr. Yi Shi is a managing partner at Lilly Asia Ventures.
- Shares held by Hopewell Resources Holdings Limited.
- Shares held by Oriental Spring Venture Limited.
- Shares held by LAV Aqua Limited.
Billionaire Hedge Funds
